IL1B and type 2 diabetes mellitus: Both these pathways are dependent on the presence of inflammatory regulators such as interleukin-1β (IL-1β), IL-6, tumor necrosis factor (TNF)-alpha, and C-reactive protein (CRP) all of which present in higher level in serum of T2DM patients compared to those without T2DM (34).